Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan.

Slides:



Advertisements
Similar presentations
Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp,
Advertisements

A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Supporting the Neonatal and Pediatric Donor Breakout Session A Presenters: Jeffrey Johnson, MD, LAC + USC Medical Center Mudit Mather, MD, Loma Linda University.
AN ANALYSIS OF CADAVER DONOR AND KIDNEY BIOPSY PARAMETERS WITH CORRELATION TO TRANSPLANT OUTCOMES Martin Mozes MD, Mel Schwartz MD, Janis Orlowski MD Michael.
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
AKI Definitions Stuart L. Goldstein, MD Professor of Pediatrics University of Cincinnati College of Medicine Director, Center for Acute Care Nephrology.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
What makes a pancreas allograft marginal? Peter J Friend University of Oxford.
Pediatric Acute Renal Failure: CRRT/Dialysis Outcome Studies Stuart L. Goldstein, MD Assistant Professor of Pediatrics Baylor College of Medicine.
Impact of expanded criteria donors on patient survival after heart, lung, liver and combined organ transplantation Quebec experience from 2003 to 2009.
Recent management of Renal Transplantation in a Developing Country like Bangladesh, R Alam, Islam M S, R Alam, H Rahman, HU Rashid Department of Nephrology,
Clinical Pharmacist Intervention in Cardiac Patients With Renal Impairment Elham Al-Shammari, B.Sc. Pharm. Hisham Abou-Auda, Ph. D. Meshal Al-Mutairi,
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Horizon Scanning on organ perfusion
Facing the Organ Shortage Crisis: Business as Usual vs Non- Conventional Solutions? Richard Perez MD Division of Transplant Surgery UC Davis Medical Center.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Early Outcomes of Transplant Recipients in the OPTN Kidney Paired Donation Pilot Program Mark Aeder, MD, University Hospitals Case Med Center Darren Stewart,
Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
© ANZOD Registry Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the.
Patient Survival USA Primary DD Pancreas Transplants 1/1/2004 – 12/31/2008 Categoryn 1Yr Surv. PTA % PAK1, % SPK4, % 2/09.
Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.
Live Donor Registry Steve Chadban. Transplant numbers.
Allocation of elderly deceased donor kidneys Lisa Bradbury, Niaz Ahmad, Paul Gibbs, Richard Baker, Adam McLean, Chris Callaghan Renal Transplant Services.
By Miss Jitjira Chaiyarit ID: The association between eGFR and Hyperosmolar Non-Ketotic Hyperglycemia Syndrome in Diabetes type 2 Doctoral.
David C. Mulligan, MD, FACS
BWGHF Liège Heart transplantation 2008.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
Comparison of HTK and UW in Abdominal Transplantation Dr. Richard S. Mangus, MD MS Indiana University, School of Medicine.
PREDICTING AKI IS MORE CHALLENGING AS AGE PROGRESSES Sandra Kane-Gill, PharmD, MSc Associate Professor, School of Pharmacy.
A Guide to the Scientific Registry of Transplant Recipients Organ Procurement Organization Reports
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo.
Experience with Calcineurin Inhibitor-Free Immunosuppression in Kidney Transplantation with Marginal Donors Oppenheimer F, Saval N, Gutierrez A, Cam pistol.
The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.
Fioretti S.; Antik A; Busto S; Bacque MC; Schiavelli R; Domenech A; Vallejos A. Analysis of Kidneys Procured by the Transplant Institute and DGF in Transplant.
DEFINING A NEW TOOL FOR LIMITING DELAYED GRAFT FUNCTION FOR KIDNEYS IN COLD STORAGE: THE MACHINE PRESERVATION TO COLD ISCHEMIA TIME RATIO Michael J. Goldstein.
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
Interobserver Reliability of Acute Kidney Injury Network (AKIN) criteria A single center cohort study Figure 2 The acute kidney injury network (AKIN) criteria.
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.
Obesity in kidney transplantation…. Dan Ridgway, Consultant Surgeon, Royal Liverpool University Hospital.
1 Kidney Transplantation Committee Spring Recent Public Comment Proposals  OPTN Kidney Paired Donation (KPD) Priority Points  Changes apply.
HEART-LUNG TRANSPLANTATION Pediatric Recipients 2015 JHLT Oct; 34(10):
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.
A2ALL When Using A2ALL Slides We welcome the use of A2ALL slides, as we value the distribution of our research for the benefit of patient care and transplant.
Thymoglobulin: An Overview of Its Performance in Clinical Trials as an Agent for the Induction Therapy Reference: Osama Gaber A, Knight RJ, Patel S, et.
Retrospective Monocentric 10-Year Analysis Of Sepsis-Associated Acute Kidney Injury: Impact On Outcome, Dialysis Dose And Residual Renal Function 1 Vincenzo.
Can we improve deceased donor kidney utilisation? Chris Callaghan National Clinical Lead for Abdominal Organ Utilisation, NHSBT Consultant Transplant Surgeon,
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
Kidney Graft Survival Rates do not improve by era: the impact of factor “Age” E. Bertoni MD, A. Larti MD, G. Rosso MD and M. Salvadori MD Renal Unit –
The ALERT Trial.
BUONA FUNZIONE RENALE DEI TRAPIANTI RENALI DA DONATORI ANZIANI VALUTATI CON CLEARANCE DELLA CREATININA SECONDO GAULT-COCKCROFT, CON DATI ECOGRAFICI E CON.
Living Donor Transplants
Careggi University Hospital–
Kidney Transplantation.
Enterprise | Interest Nothing to disclose.
C. Chalklin, C. Colmont, A. Zaidi, J. Warden-Smith, E. Ablorsu
T. Rana, L. Szabo, A. Asderakis, E. Ablorsu
Liver only transplants in the UK Question 2: In terms of survival benefit.
Risk factors in deceased-donor transplants Risk factor 1988
Risk Factors associated with Outcome
J Foland, J Fortenberry, B Warshaw,
Volume 68, Issue 5, Pages (November 2005)
Pregnancy outcomes in kidney transplant recipients
Demographic Characteristics of Cohort
Presentation transcript:

Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan

Background Extended criteria donors (ECD) kidneys are defined as those with relative risk of graft loss > 1.7 over standard kidney and include : : Kidneys from donors aged >60 years, When the donor death is due to cerebrovascular cause In the presence of donor hypertension.

With the shortage of kidneys, ECD are being increasing used. Overall, ECD Accounted for 14.8% of transplanted kidneys in 2001 (in USA) 40% were discarded compared to 8% of the standard kidneys. The high discard rate is attributed to poor organ function /quality

Background Adjusted graft survival in ECD kidneys has been reported to be 8% lower at 1 year and 15–20% lower at 3–5 years ECD kidneys render a survival benefit but should be given principally to patients over the age of 40 years and when the waiting list is long Other factors that impair graft survival include cold ischemic time (CIT), delayed graft function (DGF), terminal donor renal function.

Objective To study the graft and patient survival and graft function in Extended Criteria deceased donor kidney transplants To study the influence of recipient and donor non- immunological factors on the outcome of Extended Criteria deceased donor kidney transplants

Methods This is a retrospective study of all DD transplants that took place in the Kingdom of Saudi Arabia between from 1 / 1/2003 to 31/12/2007. The donors’ demographic data as well as SCr at kidney retrieval were obtained. CrCl was calculated using Cockcroft- Gault (CG) formula. Data collected on acute rejection, delayed graft function (DGF), cold ischemic time (CIT), graft loss, mortality, hospitalization period, SCr & calculated CrCl (CG) at last follow up,.

Methods: We studied the effects on graft survival and function of CIT, DGF, donor renal function at the time of kidney retrieval, age of the donor and recipient and transplant centers’ output volume Kaplan-Meier Method was used to calculate graft and patient survival, Chi square to compare percentages and proportions, two-tailed independent t test to compare continuous data. Multivariate analysis was performed to determine factors that may have influenced the graft outcome

Results At retrieval the frequency of donors with CrCl (CG) 40 years were 31.7% and 32% respectively. CIT > 24 hours, DGF and acute rejection (AR) occurred in 27.1 %, 33.4% and 16.5% of cases respectively. The overall 1- and 5-year graft and patient survival rates were 88% &79.8% and 96.6 % and 92.3% respectively

The graft renal function was inferior when AR occurred ( p=0.0001), with DGF (p=0.0001), with CIT > 20 hrs (p=0.005), in older recipients (p=0.002), when the donor death was non-traumatic (p=0.022), with older donors (p=0.0001) and when donor ICUs had a bed capacity of > 20 (0.03) However, the graft renal function was not influenced by the donor renal functions at retrieval donor weight or donor- recipient gender pairings

Males87.50% Mean weight (kg)65.7 (12.4) Duration in ICU (days)7.4 (6) SCr at retrieval (umol/l)153.2 (164) Serum creatinine > 150 umol/l24.7% CrCl retrieval <60 mls/min31.7% CIT > 24 hours27.1% Age > 40 years32.0% Weight > 70 Kgs27.5% Mean CIT (hours)20.2 (7.3) Donor Details ( ) (n= 273)

Male56.50% Rate of DGF33.40% Rate of rejection16.20% Graft loss by end of follow up14.50% Mean age (yrs)33.9 (14.9) Mean duration of follow up (days)626.7 (505) Mean SCr at last follow up (umol/l)127.6 (75) CrCl (CG) at last FU (mls/min)56.4 (27) Recipient Details ( ) (n= 524)

SCr umol/l) (std)PCrCl (mls/min)P With DGF (n=145)223.7 (198.5) (27) Without DGF (n=145)139.4 (139.4)61.8 (29) With acute rejection (n=74) (2606) (28) Without rejection (n=395) 149.3(120.0) 59.0 (26) CIT<20hours (n=205) (166) (26) 0.11 CIT >20 hours (n=206)159.1 (141)54.3 (28) Right (n=221) 188 (180) Left (n=247) 155 (145)58.3 Effect of Certain factors on graft function at last F/U

Factorn 1-year graft survival3-year graft survival p Cause of death traumatic Non-Traumatic Cold ischemic time hours > 20 hours Rejection yes No retrieval umole/ > 150 umole/L Number of ICU beds < 20 ICU > 20 ICU beds

SCr at retrieval <150 umol/l SCr at retrieval >150 umol/l p Frequency of acute rejection episodes15.2%20.8%0.092 Frequency of DGF29.7%45.%0.001 SCr at the end of observation period160.7 (171)143.7 (132)0.32 Two-year graft survival83.6%84.6%0.93 Two-year patient survival96.1%95.4%0.22 Effect of donor SCr at organ retrieval on acute rejection episodes, DGF & final graft SCr,

Fig 4

Conclusions The one-and 5-year graft survival rates were excellent (88 % & 79.8%). The graft function was excellent ( SCr was 127 (+/-75) umol/l & CrCl was 56.4 (27) mls/min.) Graft survival was not negatively affected by: Acute terminal rise the donor SCr. Donor age of > 50 years.

Conclusions Graft survival was negatively affected by: CIT > 20 hours. Donor ICU of < 20 beds capacity. Inferior graft function was observed when: AR occurred CIT is > 20 hours. The right donor kidney was use Donor age > 50 years